Need help? Order a test
News

Unlocking the role of genes in hereditary breast cancer

Mutations in genes only appear in 20% of women offered genetic testing for breast cancer, a new study by University of Melbourne researchers. Previously scientists believed that mutations in known breast cancer genes such as BRCA1 and BRCA2 caused cancer, but in a pioneering study, they were only present in 1 in 5 cases. Instead, […]

Read more
News

Personalised cancer treatment improves patient outcomes

Patients with advanced cancer were more likely to survive for longer or experience longer periods without disease progression if they received personalised cancer therapy, researchers at the University of California San Diego School of Medicine have found. In a recent trial, three-year survival for cancer patients receiving personalised cancer treatments was 55%, compared to 25% […]

Read more
News

Cancer diagnosis delays could cost thousands of lives

Delays to cancer diagnosis caused by COVID-19 could be responsible for thousands of avoidable deaths in the UK, a new report study published in The Lancet has found. In a ground-breaking new population-based modelling study, a London-based research team has attempted to calculate the impact of the coronavirus pandemic on cancer diagnosis and treatment outcomes. […]

Read more
News

Scientists identify new biomarker for cancer diagnosis

Scientists have identified tiny packages of materials released by tumours, called EVPs (extracellular vesicles and particles) that could be a potential biomarker for detecting several types of cancer at an early stage. In a recent study, published in the prestigious Cell journal, a US-based team have identified an exciting new biomarker that could lead to […]

Read more

Global Presence

RGCC operates in 23 countries across the world, with bases in all five continents.

Find out more